Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin. [electronic resource]
Producer: 20180329Description: 413-414 p. digitalISSN:- 1502-7732
- Adult
- Anti-Inflammatory Agents -- administration & dosage
- Antibodies, Antineutrophil Cytoplasmic -- immunology
- Autoantibodies -- blood
- Biopsy -- methods
- Female
- Granulomatosis with Polyangiitis -- diagnosis
- Humans
- Immunoglobulins, Intravenous -- administration & dosage
- Immunologic Factors -- administration & dosage
- Methylprednisolone -- administration & dosage
- Myeloblastin -- immunology
- Peritonitis -- diagnosis
- Pyoderma Gangrenosum -- diagnosis
- Respiration, Artificial -- methods
- Respiratory Insufficiency -- diagnosis
- Rituximab -- administration & dosage
- Treatment Outcome
- Vaginal Diseases -- diagnosis
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.